Acute and maintenance ECT with flupenthixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes
| Autor: | Worrawat Chanpattana, Barry Alan Kramer |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Adult
Male medicine.medical_specialty medicine.medical_treatment Global Assessment of Functioning Flupenthixol Severity of Illness Index behavioral disciplines and activities Electroconvulsive therapy Quality of life mental disorders Brief Psychiatric Rating Scale medicine Humans Electroconvulsive Therapy Antipsychotic Psychiatry Biological Psychiatry medicine.disease Combined Modality Therapy Psychiatry and Mental health Treatment Outcome Schizophrenia Acute Disease Quality of Life Female Psychology Social Adjustment Antipsychotic Agents Clinical psychology Psychopathology |
| Zdroj: | Schizophrenia Research. 63:189-193 |
| ISSN: | 0920-9964 |
| DOI: | 10.1016/s0920-9964(02)00330-4 |
| Popis: | Objective: To determine the effects of ECT combined with antipsychotic medication therapy on psychopathology, quality of life, and social functioning in patients with refractory schizophrenia. Method: An open acute (Phase I) and maintenance (Phase II) study of the combination of ECT and flupenthixol in the treatment of 46 schizophrenic patients who were nonresponsive to antipsychotic medication from at least two different classes. Scales used: the Brief Psychiatric Rating Scale (BPRS), the Quality of Life Scale (QLS), Social and Occupational Functioning Assessment Scale (SOFAS), Global Assessment of Functioning (GAF), and Mini-Mental State Exam (MMSE). The duration of Phase II was 1 year. Results: In Phase I, there were marked reductions in the BPRS scores, and substantial increases in the QLS, SOFAS, GAF, and MMSE scores. During Phase II, the BPRS negative symptoms worsened but remained improved from baseline. Changes in other outcome measures were negligible. Conclusion: ECT and MECT combined with flupenthixol were effective in improving psychopathology in patients refractory to antipsychotic medication alone. Ratings of psychopathology, quality of life, and social functioning all improved in Phase I and were generally sustained during Phase II in patients who had remitted. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect